Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Matrix metalloproteinases (MMPs) facilitate cancer invasion and metastasis by degrading the extracellular matrix (ECM).
• Matrix metalloproteinase-9 (MMP-9) mRNA is found at the interface of liver metastases and normal liver tissue, suggesting its role in liver metastasis.
• Colorectal cancer (CRC) liver metastasis formation is a significant clinical challenge.

Purpose of the Study:

• To analyze the cellular enzymatic expression of MMP-9 in human colorectal cancer liver metastasis specimens.
• To investigate the presence and form of MMP-9 in both metastatic and adjacent normal liver tissues.
• To determine if MMP-9 activation is a critical event in colorectal cancer liver metastasis.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) to quantify latent MMP-9 levels.
• Gelatin zymography to detect latent and active forms of MMP-9.
• Western blot analysis to confirm MMP-9 forms.

Main Results:

• Latent MMP-9 was detected in both liver metastases and adjacent normal liver tissues, with no significant difference in levels.
• The active form of MMP-9 (82 kDa band) was exclusively observed in liver metastasis specimens.
• Gelatin zymography and Western blot confirmed the unique presence of active MMP-9 in metastases.

Conclusions:

• The active form of MMP-9 is uniquely present in colorectal cancer liver metastases.
• ProMMP-9 activation appears to be a pivotal event in the formation of liver metastases from colorectal cancer.
• Targeting MMP-9 activation may offer a therapeutic strategy for inhibiting CRC liver metastasis.